Agreement signedPublished 21 Jun 2023

Fall Line /
GreenLight

Fall Line Capital to Acquire GreenLight Biosciences

Price per share
$0.30/share
Stage
Agreement signed
Buy side: Fall Line
Buy sideFall Line
Target: GreenLight
TargetGreenLight
Source · 21 Jun 2023
Buy side: Fall Line
Buy sideFall Line
Target: GreenLight
TargetGreenLight
01 / BuyerFall Line
02 / TargetGreenLight
01

What happened

Fall Line Capital, LLC will acquire GreenLight Biosciences Holdings, PBC in a cash transaction. The offer price is $0.30 per share.

The merger agreement provides for GreenLight to become a wholly owned subsidiary of SW ParentCo, Inc. Terms weren't disclosed.

02

Who is involved, and the source

Everything on this page comes from the source below.

Advisers

Target

Advisers are not parties to the deal.

01
Source · Original source

Fall Line Capital to Acquire GreenLight Biosciences

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.